NCT07409090

Micro-Coring® for the Treatment of Skin Laxity of the Knees

Evaluation of Micro-Coring® Technology for the Treatment of Skin Laxity of the Knees: A Prospective, Multi-Center Clinical Study

• Status: Enrolling By Invitation
• Phase: N/A
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: Cytrellis Biosystems, Inc. · Industry
• Sex: All
• Age: 22 Years – 70 Years
• Healthy volunteers: Accepted

Summary

Early, informal clinical experience suggests that Micro-Coring may help improve skin quality in certain body areas, such as the knees. However, this body region has not yet been formally studied. Additional clinical evaluation is needed to better understand healing, potential side effects, patient experience, ease of use, and optimal treatment settings for body sites. This is especially important because body skin differs from facial skin in thickness, blood supply, movement, and mechanical stress, which may affect both safety and healing outcomes.

Conditions

• Body
• Knees

Interventions

Type	Name	Description
DEVICE	Micro-Coring	Non-thermal device

Timeline

• Start date: 2026-02-02
• Primary completion: 2026-06-01
• Completion: 2026-08-01
• First posted: 2026-02-13
• Last updated: 2026-02-13

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study